202 related articles for article (PubMed ID: 17414587)
21. Masked hypertension unfavourably affects haemostasis parameters.
Papadopoulos DP; Thomopoulos C; Mourouzis I; Kotrotsou A; Sanidas E; Papazachou U; Daskalaki M; Makris TK
Blood Press; 2011 Aug; 20(4):218-21. PubMed ID: 21388252
[TBL] [Abstract][Full Text] [Related]
22. Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.
Hankey CR; Lean ME; Lowe GD; Rumley A; Woodward M
Eur J Clin Nutr; 2002 Oct; 56(10):1039-45. PubMed ID: 12373626
[TBL] [Abstract][Full Text] [Related]
23. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S
Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643
[TBL] [Abstract][Full Text] [Related]
24. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
25. [Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects].
Xiong X; Wang Z; Zhao S
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):65-7. PubMed ID: 11938745
[TBL] [Abstract][Full Text] [Related]
26. Enhanced levels of tissue-type plasminogen activator in borderline hypertension.
Wall U; Jern C; Bergbrant A; Jern S
Hypertension; 1995 Nov; 26(5):796-800. PubMed ID: 7591020
[TBL] [Abstract][Full Text] [Related]
27. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
28. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
29. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
30. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
[TBL] [Abstract][Full Text] [Related]
31. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
32. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
Huber K; Beckmann R; Frank H; Kneussl M; Mlczoch J; Binder BR
Am J Respir Crit Care Med; 1994 Oct; 150(4):929-33. PubMed ID: 7921465
[TBL] [Abstract][Full Text] [Related]
34. Effect of spironolactone on impaired fibrinolysis of hypertensive patients.
Yalcin AI; Dincer M; Aslan V; Gulbas Z
Kidney Blood Press Res; 2002; 25(4):260-4. PubMed ID: 12424430
[TBL] [Abstract][Full Text] [Related]
35. Effect of blood passage through the pulmonary circulation on fibrinolytic parameters.
Kloboves-Prevodnik V; Sabovic M; Keber D
Heart Vessels; 2004 Jan; 19(1):33-7. PubMed ID: 14685753
[TBL] [Abstract][Full Text] [Related]
36. Function of dynamically stimulated endothelium and renin-angiotensin-aldosterone system in normotensive subjects with a family history of hypertension.
Usalan C; Buyukhatipoglu H; Tiryaki O; Sahin A
Nephrology (Carlton); 2008 Dec; 13(8):689-93. PubMed ID: 19154322
[TBL] [Abstract][Full Text] [Related]
37. Comparison of plasma viscosity and fibrinogen concentration in hypertensive and normotensive diabetics.
Khan TM; Marwat MA; Rehman H
J Ayub Med Coll Abbottabad; 2005; 17(4):45-7. PubMed ID: 16599034
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
[TBL] [Abstract][Full Text] [Related]
39. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T; Bai H; Liu B; Liu Y; Zhang Z; Deng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[TBL] [Abstract][Full Text] [Related]
40. Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway.
Giannarelli C; Virdis A; De Negri F; Duranti E; Magagna A; Ghiadoni L; Salvetti A; Taddei S
Hypertension; 2008 Aug; 52(2):314-21. PubMed ID: 18574075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
